405 IAC 5-37-2 - Tobacco dependence products

Current through December 29, 2021

Authority: IC 12-15-1-10; IC 12-15-21-2; IC 12-15-21-3

Affected: IC 12-15

Sec. 2.

(a) Reimbursement is available to pharmacy providers for tobacco dependence products when prescribed by a practitioner within the scope of his or her license under Indiana law.
(b) In order for a pharmacy provider to receive reimbursement under this section for tobacco dependence products, the tobacco dependence product must be covered by Indiana Medicaid in accordance with 405 IAC 5-24-3 or 405 IAC 5-24-5.
(c) A member prescribed a legend or nonlegend drug intended to reduce an individual's [sic] dependence on tobacco products must engage in tobacco dependence counseling in conjunction with the receipt of said legend or nonlegend drug therapy.


405 IAC 5-37-2
Office ofthe Secretary of Family and Social Services; 405 IAC 5-37-2; filed Sep 27, 1999, 8:55 a.m.: 23 IR 324; readopted filed Jun 27, 2001, 9:40 a.m.: 24 IR 3822; readopted filed Sep 19, 2007, 12:16p.m.: 20071010-IR-405070311RFA; readopted filed Oct 28, 2013, 3:18 p.m.: 20131127-IR-405130241RFA Filed 5/27/2016, 12:05 p.m.: 20160622-IR-405140338FRA Errata filed 11/1/2016, 9:36 a.m.: 20161109-IR-405160493ACA

The following state regulations pages link to this page.

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.